Resources

Building Evidence for Advancing New Treatment for Rifampicin Resistant Tuberculosis Comparing a Short Course of Treatment With the Current South African Standard of Care.

ClinicalTrials.gov

Provides information on a clinical trial to compare the efficacy and safety of a Study Strategy consisting of 6 months of bedaquiline (BDQ), delamanid (DLM), and linezolid (LNZ), with levofloxacin (LVX) and clofazimine (CFZ) compared to the current South African Standard of Care (Control Strategy) for 9 months for the treatment of rifampicin resistant (RR-TB) Tuberculosis.

Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021

GBD 2021 Forecasting Collaborators

Provides forecasts and scenario analyses of global disease burden, life expectancy, and risk factor impacts for 204 countries and territories to 2050 to support health policy planning.

Can investors help women’s health break through the glass ceiling?

Deloitte

Summarizes US health tech and women’s health investment trends, challenges, and opportunities, providing data and insights to inform stakeholders and guide strategic decisions.

Cardiovascular Disease and the Female Disadvantage

Woodward, M. 

Summarizes sex differences in cardiovascular disease, highlighting female disadvantages in risk, treatment, and research, to inform improved women's health strategies.

Cell Therapy In The Treatment Of Female Stress Urinary Incontinence: Current Status And Future Proposals

González Enguita et al.

Reviews clinical data, safety, efficacy, and challenges of cell therapy for female stress urinary incontinence to guide future research and clinical practice.

Chemo-immunotherapy: A New Trend In Cancer Treatment

Sordo-Bahamonde et al.

Reviews recent advances, mechanisms, clinical approvals, efficacy, challenges, and future directions of chemo-immunotherapy combinations for cancer treatment.

ClinicalTrials.gov

National Library of Medicine

Provides information on clinical studies, including trial design, eligibility, locations, and results, to support patients, healthcare professionals, and researchers in decision-making.

Closing the women’s health gap: A $1 trillion opportunity to improve lives and economies

McKinsey Health Institute

Summarizes data on the global women’s health gap, its economic impact, root causes, and strategies to improve health equity and drive economic growth.

Common Data Set for Adverse Event Data Exchange Between IMDRF Regulators

IMDRF

Provides information on the structure, fields, and use of a Common Data Set for international adverse event data exchange between medical device regulators.

ConcePTION data

IMI ConcePTION

Provides information on medicine safety during pregnancy and breastfeeding, offering research data, guidelines, and tools to support informed healthcare decisions for women and professionals.

Contraception R&D: Broadening Horizons To Meet A Diversity Of Needs

Impact Global Health

Summarizes global funding trends, key funders, and R&D focus areas in contraception to inform investment and innovation for diverse user needs.

Contraceptive Market Size & Share Analysis Report, 2030

Grand View Research

Provides information on global contraceptives market size, trends, growth drivers, segment analysis, and forecasts for strategic business and investment decisions.